|Bid||4,100.00 x 51000|
|Ask||4,400.00 x 53800|
|Day's range||4,079.00 - 4,166.50|
|52-week range||4,025.00 - 5,377.00|
|PE ratio (TTM)||127.89|
|Earnings date||3 Aug 2017|
|Dividend & yield||0.26 (0.49%)|
|1y target est||74.22|
Shire to announce second quarter 2017 results Dublin, Ireland - July 18, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), will announce second quarter 2017 earnings on Thursday August 3, 2017. Results press ...
Shire Expands Broad Monoclonal Antibody Research Platform, Enters License Agreement for Novimmune Bi-specific Antibody Shire obtains worldwide license to pursue development and commercialization of a novel, ...
The chief executive of Shire has questioned investors' valuation of his company, arguing the potential of a number of promising drugs has yet to be factored into its share price. Flemming Ornskov also ...